HADHA in cardiovascular disease: From mitochondrial dysfunction to therapeutic targets
Ageing Research Reviews · 2026-06 · 118 · 103106
DOI: 10.1016/j.arr.2026.103106 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Ageing Research Reviews, 2026-06. Verfasst von Yichen Qi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510080, China. Electronic address: qiych6@mail2.sysu.edu…. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Mitochondria, Mitochondria, Heart, Mitochondrial Membrane Transport Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 188 Literaturangaben. Gefördert von: Guangdong Provincial Natural Science Foundation, Guangzhou Science and Technology Program Key Projects, Special Funds for the Basic Research and Development Program in the Central Non-profit Research Institutes of China.
Abstract (Originalsprache)
HADHA, encoding the α-subunit of MTP, plays a pivotal role in long-chain fatty acid β-oxidation and mitochondrial energy homeostasis. HADHA dysfunction disrupts energy balance by causing toxic metabolite buildup, impairing oxidative phosphorylation, and aberrant cardiolipin remodeling. These disturbances contribute to metabolic dysfunction and the development of cardiovascular diseases. This review summarizes the structural biology, metabolic functions, and regulatory mechanism of HADHA. We further explore its role in cardiac metabolic remodeling, underscoring its involvement in various cardiovascular diseases. In addition, we discuss emerging therapeutic strategies targeting HADHA-related pathways, including molecular interventions and metabolic modulation. By integrating molecular insights with clinical applications, this review highlights HADHA as a promising target in cardiovascular precision medicine and offers new approaches for diagnosing and treating fatty acid oxidation disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510080, China. Electronic address: qiych6@mail2.sysu.edu.cn.
- Department of Cardiology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510080, China; Key Laboratory of Assisted Circulation and Vascular Diseases, Chinese Academy of Medical Sciences, Guangzhou 51…
- Department of Geriatric, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China. Electronic address: caixm@mail.sysu.edu.cn.
- Department of Cardiology, Sanming First Affiliated Hospital of Fujian Medical University, Sanming, Fujian, China. Electronic address: 13507580119@139.com.
- Department of Cardiology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510080, China. Electronic address: chenyil7@mail.sysu.edu.cn.
Förderung
- Guangdong Provincial Natural Science Foundation
- Guangzhou Science and Technology Program Key Projects
- Special Funds for the Basic Research and Development Program in the Central Non-profit Research Institutes of China
- Chinese Academy of Medical Sciences
- National Natural Science Foundation of China
Zitieren
APA
Qi, Y., Guo, S., Cai, X., Liu, C., Dong, Y., Chen, X., Chen, Y., & Zhu, W. (2026). HADHA in cardiovascular disease: From mitochondrial dysfunction to therapeutic targets. Ageing Research Reviews, 118, 103106. https://doi.org/10.1016/j.arr.2026.103106
Vancouver
Qi Y, Guo S, Cai X, Liu C, Dong Y, Chen X, et al. HADHA in cardiovascular disease: From mitochondrial dysfunction to therapeutic targets. Ageing Research Reviews. 2026;118:103106. doi:10.1016/j.arr.2026.103106
BibTeX
@article{Qi2026,
author = {Qi, Yichen and Guo, Siyu and Cai, Xinming and Liu, Chen and Dong, Yugang and Chen, Xi and Chen, Yili and Zhu, Wengen},
title = {HADHA in cardiovascular disease: From mitochondrial dysfunction to therapeutic targets},
journal = {Ageing Research Reviews},
year = {2026},
volume = {118},
pages = {103106},
doi = {10.1016/j.arr.2026.103106}
}
EUVIMED